SCOPUS 정보 검색 플랫폼

Annals of Pharmacotherapy

Volumn 38, Issue 3, 2004, Pages 411-413

Serotonin Syndrome Resulting from Coadministration of Tramadol, Venlafaxine, and Mirtazapine

(1) Houlihan, David J a

a VETERANS AFFAIRS MEDICAL CENTER (United States)

Author keywords

Mirtazapine; Serotonin syndrome; Tramadol; Venlafaxine

Indexed keywords

MIRTAZAPINE; PSYCHOTROPIC AGENT; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; TRAMADOL; VENLAFAXINE;

ADULT; AGITATION; ARTICLE; CASE REPORT; CHRONIC PAIN; CLINICAL FEATURE; CONFUSION; DIAPHORESIS; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG POTENTIATION; DRUG UPTAKE; FEVER; HUMAN; HYPERREFLEXIA; IATROGENIC DISEASE; MAJOR DEPRESSION; MALE; MYDRIASIS; MYOCLONUS; NEUROTRANSMISSION; POLYPHARMACY; PRIORITY JOURNAL; SEROTONIN RELEASE; SEROTONIN SYNDROME; SEROTONINERGIC SYSTEM; SHIVERING; SIDE EFFECT; TACHYCARDIA;

ANALGESICS, OPIOID; ANTIDEPRESSIVE AGENTS; CYCLOHEXANOLS; DEPRESSIVE DISORDER; HUMANS; MALE; MIANSERIN; MIDDLE AGED; PAIN; POLYPHARMACY; SEROTONIN SYNDROME; TRAMADOL;

EID: 1242271414 PISSN: 10600280 EISSN: None Source Type: Journal
DOI: 10.1345/aph.1D344 Document Type: Article

Times cited : (105)

References (22)

1
- 0000632948
- Neurological effects of tryptophan in patients receiving a monoamine oxidase inhibitor
- Oates JA, Sjoerdsma A. Neurological effects of tryptophan in patients receiving a monoamine oxidase inhibitor. Neurology 1960;10:1076-8.
- (1960) Neurology , vol.10 , pp. 1076-1078
- Oates, J.A.¹ Sjoerdsma, A.²

2
- 0028835745
- Serotonin syndrome
- Bodner RA, Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurology 1995;45:219-23.
- (1995) Neurology , vol.45 , pp. 219-223
- Bodner, R.A.¹ Lynch, T.² Lewis, L.³ Kahn, D.⁴

3
- 0032824204
- A post marketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the USA
- DOI 10.1016/S0376-8716(99)00041-1
- Cicero T, Adams E, Geller A, Inciardi J, Muñoz A, Schnoll S, et al. A post marketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the USA. Drug Alcohol Depend 1999;57:7-22. DOI 10.1016/S0376-8716(99)00041-1
- (1999) Drug Alcohol Depend , vol.57 , pp. 7-22
- Cicero, T.¹ Adams, E.² Geller, A.³ Inciardi, J.⁴ Muñoz, A.⁵ Schnoll, S.⁶

4
- 0033000917
- Opioid use in the management of chronic pain
- Savage SR. Opioid use in the management of chronic pain. Med Clin North Am 1999;83:761-86.
- (1999) Med Clin North Am , vol.83 , pp. 761-786
- Savage, S.R.¹

5
- 0030862983
- Serotonin syndrome
- Mills KC. Serotonin syndrome. Crit Care Clin 1997;13:764-85.
- (1997) Crit Care Clin , vol.13 , pp. 764-785
- Mills, K.C.¹

6
- 0025869797
- The serotonin syndrome
- Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13.
- (1991) Am J Psychiatry , vol.148 , pp. 705-713
- Sternbach, H.¹

7
- 85031602672
- Toxic serotonin syndrome or extrapyramidal side-effects?
- Dursun SM, Burke JG, Reveley MA. Toxic serotonin syndrome or extrapyramidal side-effects? Br J Psychiatry 2000;55:218-24.
- (2000) Br J Psychiatry , vol.55 , pp. 218-224
- Dursun, S.M.¹ Burke, J.G.² Reveley, M.A.³

8
- 0033796137
- An exploratory approach to the serotonin syndrome: An update of clinical phenomenology and revised diagnostic criteria
- DOI 10.1054/mehy.2000.1047
- Radomski JW, Dursun SM, Reveley MA, Kutcher S. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses 2000;55:218-24. DOI 10.1054/mehy.2000.1047
- (2000) Med Hypotheses , vol.55 , pp. 218-224
- Radomski, J.W.¹ Dursun, S.M.² Reveley, M.A.³ Kutcher, S.⁴

9
- 0033856331
- Serotonin syndrome
- DOI 10.1097/00005792-200007000-00001
- Mason PJ, Morris VA, Balcezak TJ. Serotonin syndrome. Medicine 2000;79:201-209. DOI 10.1097/00005792-200007000-00001
- (2000) Medicine , vol.79 , pp. 201-209
- Mason, P.J.¹ Morris, V.A.² Balcezak, T.J.³

10
- 0036210692
- Refractory chronic pain
- Clark M, Cox T. Refractory chronic pain. Psychiatr Clin North Am 2002;25:71-88.
- (2002) Psychiatr Clin North Am , vol.25 , pp. 71-88
- Clark, M.¹ Cox, T.²

11
- 0032898039
- Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser
- DOI 10.1016/S0014-2999(99)00123-5
- Gobbi M, Mennini T. Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not a 5-hydroxytryptamine releaser. Eur J Pharmacol 1999;370:23-26. DOI 10.1016/SO014-2999(99)00123-5
- (1999) Eur J Pharmacol , vol.370 , pp. 23-26
- Gobbi, M.¹ Mennini, T.²

12
- 0032557465
- Induction of 5-hydroxytryptamine release by tramadol, fenfluramine, and reserpine
- DOI 10.1016/S0014-2999(98)00195-2
- Reimann W. Induction of 5-hydroxytryptamine release by tramadol, fenfluramine, and reserpine. Eur J Pharmacol 1998;349:199-203. DOI 10.1016/S0014-2999(98)00195-2
- (1998) Eur J Pharmacol , vol.349 , pp. 199-203
- Reimann, W.¹

13
- 0031826577
- Venlafaxine-tramadol similarities
- Markowitz J, Patrick K. Venlafaxine-tramadol similarities. Med Hypotheses 1998;51:167-8.
- (1998) Med Hypotheses , vol.51 , pp. 167-168
- Markowitz, J.¹ Patrick, K.²

14
- 0036330163
- Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: Plasma level-correlated symptomatology
- DOI 10.1097/00004714-200208000-00022
- Lange-Asschenfeldt C, Weigmann H, Hiemke C, Mann K. Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma level-correlated symptomatology. J Clin Psychopharmacol 2002:22:440-1. DOI 10.1097/00004714-200208000-00022
- (2002) J Clin Psychopharmacol , vol.22 , pp. 440-441
- Lange-Asschenfeldt, C.¹ Weigmann, H.² Hiemke, C.³ Mann, K.⁴

15
- 0032834269
- Serotonin syndrome with fluoxetine plus tramadol
- Kesavan S, Sobala G. Serotonin syndrome with fluoxetine plus tramadol. J R Soc Med 1999;92:474-5.
- (1999) J R Soc Med , vol.92 , pp. 474-475
- Kesavan, S.¹ Sobala, G.²

16
- 0034970520
- Mania and tramadol-fluoxetine combination
- Gonzalez-Pinto A, Imaz H, De Heredia J, Gutierrez M, Mica J. Mania and tramadol-fluoxetine combination. Am J Psychiatry 2001;158:964-5.
- (2001) Am J Psychiatry , vol.158 , pp. 964-965
- Gonzalez-Pinto, A.¹ Imaz, H.² De Heredia, J.³ Gutierrez, M.⁴ Mica, J.⁵

17
- 0031781012
- Serotonin syndrome following the administration of tramadol with paroxetine
- DOI 10.1002/(SICI)1099-1166(199805)13:S〈343:: AIDGPS771〉3.0.CO; 2-5
- Lantz MS, Buchalter EN, Giambanco V. Serotonin syndrome following the administration of tramadol with paroxetine. Int J Geriatr Psychiatry 1998;13:343-5.
- (1998) Int J Geriatr Psychiatry , vol.13 , pp. 343-345
- Lantz, M.S.¹ Buchalter, E.N.² Giambanco, V.³

18
- 0030737615
- Serotonin syndrome attributed to tramadol addition to paroxetine therapy
- Egberts A, Borgh J, Brodie-Meijer C. Serotonin syndrome attributed to tramadol addition to paroxetine therapy. Int Clin Psychopharmacol 1997;12:181-2.
- (1997) Int Clin Psychopharmacol , vol.12 , pp. 181-182
- Egberts, A.¹ Borgh, J.² Brodie-Meijer, C.³

19
- 0031016345
- Possible serotonin syndrome associated with tramadol and sertraline coadministration
- Mason BJ, Blackburn KH. Possible serotonin syndrome associated with tramadol and sertraline coadministration. Ann Pharmacother 1997;31:175-7.
- (1997) Ann Pharmacother , vol.31 , pp. 175-177
- Mason, B.J.¹ Blackburn, K.H.²

20
- 0019799332
- A method for estimating the probability of adverse drug reactions
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
- (1981) Clin Pharmacol Ther , vol.30 , pp. 239-245
- Naranjo, C.A.¹ Busto, U.² Sellers, E.M.³ Sandor, P.⁴ Ruiz, I.⁵ Roberts, E.⁶

21
- 0031917424
- Basic psychopharmacology of antidepressants, part I: Antidepressants have seven distinct mechanisms of action
- Stephen SM. Basic psychopharmacology of antidepressants, part I: antidepressants have seven distinct mechanisms of action. J Clin Psychiatry 1998;59:5-14.
- (1998) J Clin Psychiatry , vol.59 , pp. 5-14
- Stephen, S.M.¹

22
- 0036633977
- Serotonin syndrome produced by a combination of venlafaxine and mirtazapine
- Dimellis D. Serotonin syndrome produced by a combination of venlafaxine and mirtazapine (letter). World J Biol Psychiatry 2002;3:167.
- (2002) World J Biol Psychiatry , vol.3 , pp. 167
- Dimellis, D.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.